1585186739035.jpeg

Revenues Working Against Bon Natural Life Limited’s (NASDAQ:BON) Share Price

Stock Analysis

When close to half the companies operating in the Chemicals industry in the United States have price-to-sales ratios (or “P/S”) above 1.2x, you may consider Bon Natural Life Limited (NASDAQ:BON) as an attractive investment with its 0.2x P/S ratio. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s limited.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

See our latest analysis for Bon Natural Life

ps-multiple-vs-industry
NasdaqCM:BON Price to Sales Ratio vs Industry July 8th 2025

How Has Bon Natural Life Performed Recently?

For instance, Bon…

Source link

Tags:
Facebook Google+ Twitter Pinterest

Related Posts